---
title: "BLUE SAIL MEDICAL released its performance for the first half of the year, with a net loss attributable to the parent company of 135 million yuan, narrowing by 15.88%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255150197.md"
description: "According to the Zhitong Finance APP, BLUE SAIL MEDICAL released its semi-annual report for 2025, showing an operating income of 2.781 billion yuan, a year-on-year decrease of 7.49%. The net loss attributable to shareholders of the listed company was 135 million yuan, a year-on-year narrowing of 15.88%. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 210 million yuan, a year-on-year increase of 11.82%. The basic loss per share was 0.13 yuan"
datetime: "2025-08-29T08:27:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255150197.md)
  - [en](https://longbridge.com/en/news/255150197.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255150197.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/255150197.md) | [繁體中文](https://longbridge.com/zh-HK/news/255150197.md)


# BLUE SAIL MEDICAL released its performance for the first half of the year, with a net loss attributable to the parent company of 135 million yuan, narrowing by 15.88%

According to the Zhitong Finance APP, BLUE SAIL MEDICAL (002382.SZ) released its semi-annual report for 2025, reporting an operating income of 2.781 billion yuan, a year-on-year decrease of 7.49%. The net loss attributable to shareholders of the listed company was 135 million yuan, a year-on-year narrowing of 15.88%. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 210 million yuan, a year-on-year increase of 11.82%. The basic loss per share was 0.13 yuan

### Related Stocks

- [BLUE SAIL MEDICAL (002382.CN)](https://longbridge.com/en/quote/002382.CN.md)

## Related News & Research

- [Tennis-Gauff retires from Indian Wells match due to elbow pain](https://longbridge.com/en/news/278312995.md)
- [Bug that wiped customer data saved the day – and a contract](https://longbridge.com/en/news/278347746.md)
- [Tajikistan Approves Hebei Changsha Biochemical Pharmaceutical's Thrombosis Injection](https://longbridge.com/en/news/278372421.md)
- [UK health authorities join forces to champion foreign infectious disease trials](https://longbridge.com/en/news/278723024.md)
- [10:07 ETIntune Physical Therapy Expands into Texas with Acquisition of Spero Rehab](https://longbridge.com/en/news/278571095.md)